Home/Filings/4/0001209191-21-012154
4//SEC Filing

Fotopoulos Alexandros 4

Accession 0001209191-21-012154

CIK 0001787297other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 7:24 PM ET

Size

6.4 KB

Accession

0001209191-21-012154

Insider Transaction Report

Form 4
Period: 2021-02-16
Fotopoulos Alexandros
Chief Technical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-16+105,000105,000 total
    Exercise: $21.85Exp: 2031-02-15Common Stock (105,000 underlying)
Holdings
  • Common Stock

    6,888
Footnotes (2)
  • [F1]Reflects 2020 Employee Stock Purchase Plan allocations of 1,388 shares that occurred since the date of the reporting person's last ownership report.
  • [F2]The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Passage BIO, Inc.

CIK 0001787297

Entity typeother

Related Parties

1
  • filerCIK 0001799814

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 7:24 PM ET
Size
6.4 KB